↓ Skip to main content

Edoxaban population pharmacokinetics and exposure–response analysis in patients with non-valvular atrial fibrillation

Overview of attention for article published in European Journal of Clinical Pharmacology, August 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Edoxaban population pharmacokinetics and exposure–response analysis in patients with non-valvular atrial fibrillation
Published in
European Journal of Clinical Pharmacology, August 2014
DOI 10.1007/s00228-014-1736-4
Pubmed ID
Authors

Ophelia Q. P. Yin, Kimura Tetsuya, Raymond Miller

Abstract

The aim of this study was to evaluate the population pharmacokinetics (PK) and exposure-response relationship of edoxaban in patients with non-valvular atrial fibrillation (AF).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Slovenia 1 1%
Unknown 84 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 16%
Student > Master 12 14%
Researcher 10 12%
Student > Bachelor 9 11%
Student > Doctoral Student 5 6%
Other 18 21%
Unknown 17 20%
Readers by discipline Count As %
Medicine and Dentistry 42 49%
Pharmacology, Toxicology and Pharmaceutical Science 11 13%
Biochemistry, Genetics and Molecular Biology 3 4%
Nursing and Health Professions 3 4%
Economics, Econometrics and Finance 2 2%
Other 3 4%
Unknown 21 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2014.
All research outputs
#18,381,794
of 22,768,097 outputs
Outputs from European Journal of Clinical Pharmacology
#2,221
of 2,557 outputs
Outputs of similar age
#168,263
of 236,208 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#21
of 30 outputs
Altmetric has tracked 22,768,097 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,557 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,208 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.